In its April 2019 NEWSletter, the Patented Medicine Prices Review Board (PMPRB) announced that the Steering Committee on Guidelines Modernization would hold its final meeting on May 13, 2019, to discuss both a draft report of its deliberations and the Working Group’s final report (released March 6, 2019). Once the Steering Committee’s report has been finalized and the regulatory amendments have been published in Part II of the Canada Gazette (expected this spring), the PMPRB will release its draft Guidelines for public consultation.
Related Publications & Articles
-
CDA releases strategy to improve the appropriate prescribing and use of prescription medications in Canada
On September 18, 2025, Canada’s Drug Agency (CDA) launched its new strategy to improve the appropriate prescribing and use of prescription medications in Canada.Read More -
PMPRB releases Annual Public Drug Plan Expenditure Report (2022/23)
On October 21, 2025, the Patented Medicine Prices Review Board (PMPRB) announced the release of CompassRx, an annual report that analyzes factors driving prescription drug expenditures in Canadian pub...Read More -
Ontario pilot program and pCPA new negotiation pathway aim to expedite access to breakthrough cancer treatments
The Ontario government and the pan-Canadian Pharmaceutical Alliance (pCPA) announced separate initiatives in October 2025, both aimed to accelerate patient access to breakthrough cancer treatments app...Read More
